FR2197575A1 - - Google Patents

Info

Publication number
FR2197575A1
FR2197575A1 FR7331463A FR7331463A FR2197575A1 FR 2197575 A1 FR2197575 A1 FR 2197575A1 FR 7331463 A FR7331463 A FR 7331463A FR 7331463 A FR7331463 A FR 7331463A FR 2197575 A1 FR2197575 A1 FR 2197575A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7331463A
Other languages
French (fr)
Other versions
FR2197575B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00284792A external-priority patent/US3814755A/en
Priority claimed from US00286793A external-priority patent/US3813391A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2197575A1 publication Critical patent/FR2197575A1/fr
Application granted granted Critical
Publication of FR2197575B1 publication Critical patent/FR2197575B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/28Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of CHx-moieties
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7331463A 1972-08-30 1973-08-30 Expired FR2197575B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00284792A US3814755A (en) 1972-08-30 1972-08-30 7-(omikron-aminomethylphenylacetamido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US00286793A US3813391A (en) 1972-09-06 1972-09-06 7-(beta-(o-aminomethylphenyl)propion-amido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid

Publications (2)

Publication Number Publication Date
FR2197575A1 true FR2197575A1 (en) 1974-03-29
FR2197575B1 FR2197575B1 (en) 1979-02-23

Family

ID=26962815

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7331463A Expired FR2197575B1 (en) 1972-08-30 1973-08-30

Country Status (8)

Country Link
JP (1) JPS5727116B2 (en)
DE (1) DE2343827A1 (en)
FI (1) FI57111C (en)
FR (1) FR2197575B1 (en)
GB (1) GB1406204A (en)
NL (1) NL7311757A (en)
SE (1) SE415979B (en)
YU (1) YU39712B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3382241A (en) * 1967-02-27 1968-05-07 Lilly Co Eli Certain orally active cephalosporin antibiotics
FR2137792A1 (en) * 1971-05-11 1972-12-29 Molecular Research Ltd

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3382241A (en) * 1967-02-27 1968-05-07 Lilly Co Eli Certain orally active cephalosporin antibiotics
FR2137792A1 (en) * 1971-05-11 1972-12-29 Molecular Research Ltd

Also Published As

Publication number Publication date
AU5943273A (en) 1975-02-27
JPS5727116B2 (en) 1982-06-08
FI57111C (en) 1980-06-10
GB1406204A (en) 1975-09-17
FI57111B (en) 1980-02-29
YU39712B (en) 1985-04-30
YU236173A (en) 1982-02-28
JPS49132099A (en) 1974-12-18
DE2343827A1 (en) 1974-04-25
SE415979B (en) 1980-11-17
NL7311757A (en) 1974-03-04
FR2197575B1 (en) 1979-02-23

Similar Documents

Publication Publication Date Title
FR2198005A1 (en)
IN140753B (en)
FR2167972B1 (en)
JPS4820694Y1 (en)
JPS4924735U (en)
JPS4997423U (en)
JPS48102357A (en)
JPS4982194U (en)
JPS49617U (en)
FR2197575B1 (en)
FR2279408B1 (en)
FR2197993B1 (en)
CS159552B1 (en)
CS155433B1 (en)
JPS4972650A (en)
JPS4986389U (en)
JPS4946452U (en)
RO57475A2 (en)
JPS4973058U (en)
CS162996B1 (en)
CS162529B1 (en)
CS162005B1 (en)
CS160908B1 (en)
CS150471B1 (en)
CS157947B1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse